1993). In fact, interleukin (IL)-12 is required for the induction of Th1-related chemokines such as XCL1 (also known as lymphotactin), CXCL10 [induced protein-10 (IP-10) ] and CCL2 [monocyte ...

Background: Although immune checkpoint inhibitors (ICIs) represent a substantial breakthrough in cancer treatment, it is crucial to acknowledge that their efficacy is limited to a subset of patients.

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.